As scientists continue to investigate the roots of autism, a generic cancer drug might hold the key. Leucovorin is prescribed to reduce the side effects of chemo. But in several studies conducted over ...

With the recent regulatory success of therapies targeting folate receptor alpha (FRα), a protein that is overexpressed in several tumor types and especially ovarian cancer, it’s easy to ...

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by challenges in social interaction, ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) ...

US-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its antibody-drug conjugate (ADC) Elahere against chemotherapy for treating ...

Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the ...

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits and consistent safety data.